SpectraCell is a CLIA accredited laboratory that services healthcare providers nationwide by providing advanced clinical testing with the patented FIA^TM (Functional Intracellular Analysis^TM) and LPP^TM (Lipoprotein Particle Profile^TM) tests.

Spectracell's FIA^TM test is an innovative assessment of a patient's nutritional status. Unlike traditional serum, hair and urine tests, Spectracell's FIA^TM evaluates how an individual's white blood cells respond to varied environments of over 30 vitamins, minerals, amino acids and antioxidants. As a result, individual differences in metabolism, age, genetics, health, prescription drug usage, absorption rate or other factors are taken into consideration.

Spectracell's LPP^TM test is the most advanced lipoprotein test currently available. Unlike traditional cholesterol tests, Spectracell's LPP^TM directly measures both the size and number of several classes of lipoprotein particles, including critical risk factors as cited by the National Cholesterol Education Program, giving an accurate assessment of cardiovascular risk.

A growing number of healthcare providers and patients are looking for more effective ways to address today’s most common health issues. In our ever-expanding understanding of human health, we have come to the realization that our health is never as simple as it may seem. There is an interconnectedness between the different biological systems in the body, just as there is in our external environment. Our understanding of these relationships requires a new approach to health- a systems approach- whereby the impact of each human biological system is evaluated in relationship to each other, not in isolation.

Our nervous system influences how we think, feel, and act, as well as how the rest of our body functions. At NeuroScience, we believe the function of the central nervous system, including a balance of neurotransmitters, plays an essential and central role in the health of all body systems.

We advocate an assess-address approach to nervous system function. This process entails laboratory assessment of the body’s chemical messengers, via urinary neurotransmitter and salivary hormone testing. Based on the laboratory results, NeuroScience works with healthcare providers to develop Targeted Amino Acid Therapy (TAAT^sm) programs designed to address the spectrum of neurotransmitter and hormone imbalances.

Addressing neurotransmitter and hormone imbalances through TAAT^sm can lead to significantly improved patient outcomes for a number of today’s most challenging conditions.

Doctor's Data, Inc., (DDI) a premier independent clinical laboratory with over 35 years' experience, provides specialty testing to healthcare practitioners around the world.  A specialist and pioneer in essential and toxic elemental testing of multiple human tissues, the laboratory offers a wide array of functional testing.  DDI's tests are utilized in the assessment, detection, prevention, and treatment of heavy metal burden, nutritional deficiencies, gastrointestinal function, hepatic detoxification, metabolic abnormalities, and diseases of environmental origin.  DDI is a licensed CLIA laboratory with appropriate state certifications and participates in numerous quality assurance/proficiency testing programs including the College of American Pathology, New York State DOH and Le Centre de Toxicologie du Quebec.